Pathway ID |
Pathway Name |
p-Value |
Adjusted p-Value |
Enriched Genes |
hsa05212 |
Pancreatic cancer_Homo sapiens_hsa05212 |
1.217E-05 |
7.094E-04 |
MAPK1; TP53; NFKB1 |
hsa04662 |
B cell receptor signaling pathway_Homo sapiens_hsa04662 |
1.650E-05 |
7.094E-04 |
MAPK1; NFKB1; MALT1 |
hsa05220 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 |
1.650E-05 |
7.094E-04 |
MAPK1; TP53; NFKB1 |
hsa04010 |
MAPK signaling pathway_Homo sapiens_hsa04010 |
2.337E-05 |
7.536E-04 |
MAPK1; MAPT; TP53; NFKB1 |
hsa05215 |
Prostate cancer_Homo sapiens_hsa05215 |
2.993E-05 |
7.721E-04 |
MAPK1; TP53; NFKB1 |
hsa04660 |
T cell receptor signaling pathway_Homo sapiens_hsa04660 |
4.769E-05 |
1.025E-03 |
MAPK1; NFKB1; MALT1 |
hsa04722 |
Neurotrophin signaling pathway_Homo sapiens_hsa04722 |
7.306E-05 |
1.178E-03 |
MAPK1; TP53; NFKB1 |
hsa04210 |
Apoptosis_Homo sapiens_hsa04210 |
1.155E-04 |
1.490E-03 |
MAPK1; TP53; NFKB1 |
hsa04071 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 |
7.306E-05 |
1.178E-03 |
MAPK1; TP53; NFKB1 |
hsa05160 |
Hepatitis C_Homo sapiens_hsa05160 |
9.919E-05 |
1.422E-03 |
MAPK1; TP53; NFKB1 |
hsa05161 |
Hepatitis B_Homo sapiens_hsa05161 |
1.308E-04 |
1.534E-03 |
MAPK1; TP53; NFKB1 |
hsa05203 |
Viral carcinogenesis_Homo sapiens_hsa05203 |
3.554E-04 |
2.787E-03 |
MAPK1; TP53; NFKB1 |
hsa05152 |
Tuberculosis_Homo sapiens_hsa05152 |
2.347E-04 |
2.163E-03 |
MAPK1; NFKB1; MALT1 |
hsa05223 |
Non-small cell lung cancer_Homo sapiens_hsa05223 |
6.858E-04 |
4.364E-03 |
MAPK1; TP53 |
hsa00380 |
Tryptophan metabolism_Homo sapiens_hsa00380 |
3.496E-04 |
2.787E-03 |
CYP1A2; IDO1 |
hsa05216 |
Thyroid cancer_Homo sapiens_hsa05216 |
1.828E-04 |
1.813E-03 |
MAPK1; TP53 |
hsa05213 |
Endometrial cancer_Homo sapiens_hsa05213 |
5.914E-04 |
4.238E-03 |
MAPK1; TP53 |
hsa05221 |
Acute myeloid leukemia_Homo sapiens_hsa05221 |
7.104E-04 |
4.364E-03 |
MAPK1; NFKB1 |
hsa05214 |
Glioma_Homo sapiens_hsa05214 |
9.229E-04 |
4.961E-03 |
MAPK1; TP53 |
hsa05206 |
MicroRNAs in cancer_Homo sapiens_hsa05206 |
1.045E-03 |
4.993E-03 |
MAPK1; TP53; NFKB1 |
hsa00591 |
Linoleic acid metabolism_Homo sapiens_hsa00591 |
1.828E-04 |
1.813E-03 |
CYP1A2; CYP2C19 |
hsa05219 |
Bladder cancer_Homo sapiens_hsa05219 |
3.673E-04 |
2.787E-03 |
MAPK1; TP53 |
hsa05210 |
Colorectal cancer_Homo sapiens_hsa05210 |
8.400E-04 |
4.926E-03 |
MAPK1; TP53 |
hsa04151 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 |
1.555E-03 |
5.927E-03 |
MAPK1; TP53; NFKB1 |
hsa05230 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 |
9.802E-04 |
4.993E-03 |
MAPK1; TP53 |
hsa04621 |
NOD-like receptor signaling pathway_Homo sapiens_hsa04621 |
7.104E-04 |
4.364E-03 |
MAPK1; NFKB1 |
hsa05218 |
Melanoma_Homo sapiens_hsa05218 |
1.100E-03 |
4.998E-03 |
MAPK1; TP53 |
hsa04917 |
Prolactin signaling pathway_Homo sapiens_hsa04917 |
1.131E-03 |
4.998E-03 |
MAPK1; NFKB1 |
hsa00982 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 |
1.039E-03 |
4.993E-03 |
CYP1A2; CYP2C19 |
hsa05131 |
Shigellosis_Homo sapiens_hsa05131 |
9.229E-04 |
4.961E-03 |
MAPK1; NFKB1 |
hsa05200 |
Pathways in cancer_Homo sapiens_hsa05200 |
2.401E-03 |
7.461E-03 |
MAPK1; TP53; NFKB1 |
hsa05140 |
Leishmaniasis_Homo sapiens_hsa05140 |
1.162E-03 |
4.998E-03 |
MAPK1; NFKB1 |
hsa04933 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 |
2.209E-03 |
7.461E-03 |
MAPK1; NFKB1 |
hsa05222 |
Small cell lung cancer_Homo sapiens_hsa05222 |
1.608E-03 |
5.927E-03 |
TP53; NFKB1 |
hsa04211 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 |
1.917E-03 |
6.684E-03 |
TP53; NFKB1 |
hsa05133 |
Pertussis_Homo sapiens_hsa05133 |
1.226E-03 |
5.103E-03 |
MAPK1; NFKB1 |
hsa04066 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 |
2.296E-03 |
7.461E-03 |
MAPK1; NFKB1 |
hsa05204 |
Chemical carcinogenesis_Homo sapiens_hsa05204 |
1.464E-03 |
5.900E-03 |
CYP1A2; CYP2C19 |
hsa04064 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 |
1.877E-03 |
6.684E-03 |
NFKB1; MALT1 |
hsa04620 |
Toll-like receptor signaling pathway_Homo sapiens_hsa04620 |
2.429E-03 |
7.461E-03 |
MAPK1; NFKB1 |
hsa05142 |
Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 |
2.340E-03 |
7.461E-03 |
MAPK1; NFKB1 |
hsa04668 |
TNF signaling pathway_Homo sapiens_hsa04668 |
2.613E-03 |
7.838E-03 |
MAPK1; NFKB1 |
hsa05132 |
Salmonella infection_Homo sapiens_hsa05132 |
1.608E-03 |
5.927E-03 |
MAPK1; NFKB1 |
hsa04726 |
Serotonergic synapse_Homo sapiens_hsa04726 |
2.707E-03 |
7.936E-03 |
MAPK1; CYP2C19 |
hsa05145 |
Toxoplasmosis_Homo sapiens_hsa05145 |
2.999E-03 |
8.409E-03 |
MAPK1; NFKB1 |
hsa04919 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 |
2.999E-03 |
8.409E-03 |
MAPK1; TP53 |
hsa04380 |
Osteoclast differentiation_Homo sapiens_hsa04380 |
3.735E-03 |
1.004E-02 |
MAPK1; NFKB1 |
hsa05162 |
Measles_Homo sapiens_hsa05162 |
3.959E-03 |
1.042E-02 |
TP53; NFKB1 |
hsa05164 |
Influenza A_Homo sapiens_hsa05164 |
6.465E-03 |
1.635E-02 |
MAPK1; NFKB1 |
hsa05010 |
Alzheimer's disease_Homo sapiens_hsa05010 |
5.973E-03 |
1.541E-02 |
MAPK1; MAPT |
hsa05169 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 |
8.528E-03 |
1.948E-02 |
TP53; NFKB1 |
hsa05202 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 |
6.827E-03 |
1.694E-02 |
TP53; NFKB1 |
hsa04062 |
Chemokine signaling pathway_Homo sapiens_hsa04062 |
7.349E-03 |
1.756E-02 |
MAPK1; NFKB1 |
hsa05205 |
Proteoglycans in cancer_Homo sapiens_hsa05205 |
8.609E-03 |
1.948E-02 |
MAPK1; TP53 |
hsa05168 |
Herpes simplex infection_Homo sapiens_hsa05168 |
7.198E-03 |
1.752E-02 |
TP53; NFKB1 |
hsa04024 |
cAMP signaling pathway_Homo sapiens_hsa04024 |
8.286E-03 |
1.943E-02 |
MAPK1; NFKB1 |
hsa04014 |
Ras signaling pathway_Homo sapiens_hsa04014 |
1.067E-02 |
2.333E-02 |
MAPK1; NFKB1 |
hsa05166 |
HTLV-I infection_Homo sapiens_hsa05166 |
1.362E-02 |
2.928E-02 |
TP53; NFKB1 |
hsa05143 |
African trypanosomiasis_Homo sapiens_hsa05143 |
2.423E-02 |
4.884E-02 |
IDO1 |
hsa05020 |
Prion diseases_Homo sapiens_hsa05020 |
2.423E-02 |
4.884E-02 |
MAPK1 |
hsa00052 |
Galactose metabolism_Homo sapiens_hsa00052 |
2.080E-02 |
4.328E-02 |
GLA |
hsa04320 |
Dorso-ventral axis formation_Homo sapiens_hsa04320 |
1.874E-02 |
3.963E-02 |
MAPK1 |
hsa00603 |
Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 |
9.759E-03 |
2.170E-02 |
GLA |
hsa00232 |
Caffeine metabolism_Homo sapiens_hsa00232 |
3.495E-03 |
9.594E-03 |
CYP1A2 |